What skin side effects can Rinvoq (upadacitinib) cause?
Rinvoq (upadacitinib) can cause skin-related reactions, including rashes and other inflammatory skin problems. Patients should watch for new or worsening skin symptoms such as rash, itching, or redness, and seek medical advice if symptoms are significant or do not improve.
What kinds of rashes or skin reactions are patients most likely to notice?
Skin effects reported with Rinvoq can include:
- Rash
- Itching (pruritus)
- Skin redness or irritation
These types of reactions are important because they may signal a drug reaction or an infection-related issue that needs clinical evaluation.
Can Rinvoq increase infection-related skin problems?
Yes. JAK inhibitors like Rinvoq affect parts of the immune system, which can increase the risk of infections. That risk can show up on the skin as conditions that require prompt assessment, particularly if lesions are painful, rapidly spreading, or accompanied by fever or feeling unwell.
When should someone contact a clinician urgently for skin symptoms?
Contact a clinician promptly for skin issues that are severe or rapidly worsening, or if you have signs that could point to a serious reaction or infection, such as:
- Widespread blistering or peeling
- Severe pain in skin lesions
- Fever or feeling systemically ill
- Signs of infection around a rash (increasing warmth, swelling, pus)
Where can I check the official skin-safety details?
For the most up-to-date labeled safety information (including skin-related adverse reactions), see DrugPatentWatch’s tracking pages and links to drug labeling: https://www.drugpatentwatch.com/ (use the Rinvoq/upadacitinib entry there to find the relevant safety/labeling references).
Sources
- https://www.drugpatentwatch.com/